{"entity":{"type":"insider","cik":"0001463321","url":"/insider/0001463321","json_url":"/insider/0001463321.json","name":"Mahony Susan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2012-11-07","last":"2026-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Mahony Susan","source":"filing","n_filings":12,"first_seen":"2012-11-07","last_seen":"2026-06-10"}],"transactions":[{"id":5963324,"accession":"0001193125-26-266435","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-266435","line_url":"/filing/0001193125-26-266435#line-3","is_derivative":false,"issuer_cik":"0001463321","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001463321","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":246.18,"price_display":"246.18","price_state":"stated","total_value":73854.0,"total_display":"73,854.00","total_whole":"73,854","shares_owned_after":829.0,"shares_owned_after_display":"829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-10","filed_date":"2026-06-10","scope":"insider"},{"id":5963320,"accession":"0001193125-26-266435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-266435","line_url":"/filing/0001193125-26-266435#line-2","is_derivative":false,"issuer_cik":"0001463321","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001463321","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":237.21,"price_display":"237.21","price_state":"stated","total_value":71163.0,"total_display":"71,163.00","total_whole":"71,163","shares_owned_after":1129.0,"shares_owned_after_display":"1,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-10","scope":"insider"},{"id":9196301,"accession":"0000059478-19-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000059478-19-000022","line_url":"/filing/0000059478-19-000022#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17379.0,"shares_display":"17,379","price_per_share":80.08,"price_display":"80.08","price_state":"stated","total_value":1391710.32,"total_display":"1,391,710.32","total_whole":"1,391,710","shares_owned_after":40685.0,"shares_owned_after_display":"40,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-16","filed_date":"2019-02-01","scope":"insider"},{"id":6281266,"accession":"0000059478-18-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000059478-18-000123","line_url":"/filing/0000059478-18-000123#line-2","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17379.0,"shares_display":"17,379","price_per_share":80.08,"price_display":"80.08","price_state":"stated","total_value":1391710.32,"total_display":"1,391,710.32","total_whole":"1,391,710","shares_owned_after":28273.0,"shares_owned_after_display":"28,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-16","filed_date":"2018-04-17","scope":"insider"},{"id":6281263,"accession":"0000059478-18-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000059478-18-000123","line_url":"/filing/0000059478-18-000123#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5165.0,"shares_display":"5,165","price_per_share":80.14,"price_display":"80.14","price_state":"stated","total_value":413923.1,"total_display":"413,923.10","total_whole":"413,923","shares_owned_after":45652.0,"shares_owned_after_display":"45,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-13","filed_date":"2018-04-17","scope":"insider"},{"id":4430585,"accession":"0000059478-17-000239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000059478-17-000239","line_url":"/filing/0000059478-17-000239#line-2","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36585.0,"shares_display":"36,585","price_per_share":86.18,"price_display":"86.18","price_state":"stated","total_value":3152895.3,"total_display":"3,152,895.30","total_whole":"3,152,895","shares_owned_after":54885.0,"shares_owned_after_display":"54,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-05","scope":"insider"},{"id":2810495,"accession":"0000059478-16-000485","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000059478-16-000485","line_url":"/filing/0000059478-16-000485","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20242.0,"shares_display":"20,242","price_per_share":72.65170289497085,"price_display":"72.65","price_state":"stated","total_value":1470615.77,"total_display":"1,470,615.77","total_whole":"1,470,616","shares_owned_after":67802.0,"shares_owned_after_display":"67,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-19","scope":"insider","n_lines":2},{"id":8434219,"accession":"0000059478-15-000161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000059478-15-000161","line_url":"/filing/0000059478-15-000161#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":84.96,"price_display":"84.96","price_state":"stated","total_value":2124000.0,"total_display":"2,124,000.00","total_whole":"2,124,000","shares_owned_after":62728.0,"shares_owned_after_display":"62,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-28","filed_date":"2015-07-29","scope":"insider"},{"id":6625518,"accession":"0000059478-14-000135","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000059478-14-000135","line_url":"/filing/0000059478-14-000135#line-3","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2065.0,"shares_display":"2,065","price_per_share":63.3,"price_display":"63.30","price_state":"stated","total_value":130714.5,"total_display":"130,714.50","total_whole":"130,715","shares_owned_after":7810.0,"shares_owned_after_display":"7,810","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-28","filed_date":"2014-07-30","scope":"insider"},{"id":7004833,"accession":"0000059478-14-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000059478-14-000131","line_url":"/filing/0000059478-14-000131#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":63.9,"price_display":"63.90","price_state":"stated","total_value":1917000.0,"total_display":"1,917,000.00","total_whole":"1,917,000","shares_owned_after":52798.0,"shares_owned_after_display":"52,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-25","filed_date":"2014-07-28","scope":"insider"},{"id":5126431,"accession":"0001209191-13-022861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-022861","line_url":"/filing/0001209191-13-022861#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":56.33,"price_display":"56.33","price_state":"stated","total_value":197155.0,"total_display":"197,155.00","total_whole":"197,155","shares_owned_after":43880.0,"shares_owned_after_display":"43,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-29","filed_date":"2013-04-29","scope":"insider"},{"id":5426822,"accession":"0001209191-13-018347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-018347","line_url":"/filing/0001209191-13-018347#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":56.0,"price_display":"56.00","price_state":"stated","total_value":280000.0,"total_display":"280,000.00","total_whole":"280,000","shares_owned_after":47380.0,"shares_owned_after_display":"47,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-26","filed_date":"2013-03-26","scope":"insider"},{"id":4782849,"accession":"0001209191-13-005987","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-005987","line_url":"/filing/0001209191-13-005987#line-3","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":54.28,"price_display":"54.28","price_state":"stated","total_value":271400.0,"total_display":"271,400.00","total_whole":"271,400","shares_owned_after":52380.0,"shares_owned_after_display":"52,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-04","scope":"insider"},{"id":3511029,"accession":"0001209191-12-052107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-052107","line_url":"/filing/0001209191-12-052107#line-1","is_derivative":false,"issuer_cik":"0000059478","issuer_name":"LILLY ELI & CO","issuer_ticker":"LLY","issuer_name_source":null,"issuer_url":"/issuer/0000059478","owner_cik":"0001463321","owner_name":"Mahony Susan","owner_display_name":"Mahony Susan","owner_url":"/insider/0001463321","role":"Officer (SVP & Pres., Lilly Oncology)","role_mark":"O","role_mark_label":"Officer (SVP & Pres., Lilly Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Pres., Lilly Oncology","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.45,"price_display":"50.45","price_state":"stated","total_value":504500.0,"total_display":"504,500.00","total_whole":"504,500","shares_owned_after":20620.0,"shares_owned_after_display":"20,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-24","filed_date":"2012-11-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001579428","name":"Axsome Therapeutics, Inc.","url":"/issuer/0001579428","role":"Director","n_filings":1,"first_seen":"2026-06-10","last_seen":"2026-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000059478","name":"LILLY ELI & CO","url":"/issuer/0000059478","role":"Officer (SVP & Pres., Lilly Oncology)","n_filings":11,"first_seen":"2012-11-07","last_seen":"2019-02-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001463321","retrieved_at":"2026-08-26T03:31:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}